TransMedics Other Liab vs Accounts Payable Analysis

TMDX Stock  USD 122.00  3.34  2.81%   
TransMedics financial indicator trend analysis is much more than just breaking down TransMedics Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TransMedics Group is a good investment. Please check the relationship between TransMedics Other Liab and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Other Liab vs Accounts Payable

Other Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TransMedics Group Other Liab account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between TransMedics' Other Liab and Accounts Payable is -0.36. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of TransMedics Group, assuming nothing else is changed. The correlation between historical values of TransMedics' Other Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of TransMedics Group are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Other Liab i.e., TransMedics' Other Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.36
Relationship DirectionNegative 
Relationship StrengthInsignificant

Other Liab

Accounts Payable

An accounting item on the balance sheet that represents TransMedics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of TransMedics Group are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from TransMedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TransMedics Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, TransMedics' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.96 in 2024, despite the fact that Tax Provision is likely to grow to (1.4 M).
 2021 2022 2023 2024 (projected)
Total Operating Expenses60.6M96.7M153.5M161.2M
Research Development22.3M26.8M36.1M22.2M

TransMedics fundamental ratios Correlations

0.980.7-0.090.81-0.750.860.99-0.120.98-0.370.990.941.00.610.910.960.990.72-0.090.980.980.960.640.98-0.29
0.980.7-0.160.8-0.80.920.96-0.060.97-0.370.990.950.980.640.930.980.980.73-0.040.970.970.940.650.97-0.23
0.70.7-0.120.93-0.740.470.690.060.59-0.080.730.530.730.960.830.810.70.87-0.240.60.580.520.160.58-0.1
-0.09-0.16-0.120.00.12-0.36-0.08-0.44-0.170.17-0.14-0.2-0.07-0.090.01-0.14-0.110.240.35-0.16-0.13-0.14-0.34-0.14-0.31
0.810.80.930.0-0.750.580.79-0.270.71-0.050.820.660.850.860.890.870.810.84-0.20.720.710.650.270.71-0.43
-0.75-0.8-0.740.12-0.75-0.69-0.720.01-0.660.01-0.81-0.66-0.78-0.79-0.82-0.82-0.73-0.790.01-0.66-0.65-0.6-0.27-0.650.15
0.860.920.47-0.360.58-0.690.82-0.020.9-0.320.880.870.840.440.750.840.850.48-0.150.90.890.880.750.89-0.17
0.990.960.69-0.080.79-0.720.82-0.080.96-0.50.980.930.980.590.930.951.00.71-0.070.960.960.940.560.96-0.23
-0.12-0.060.06-0.44-0.270.01-0.02-0.08-0.05-0.31-0.06-0.07-0.140.1-0.1-0.02-0.080.0-0.04-0.05-0.08-0.040.06-0.070.97
0.980.970.59-0.170.71-0.660.90.96-0.05-0.420.970.970.960.490.830.930.970.62-0.071.01.01.00.771.0-0.22
-0.37-0.37-0.080.17-0.050.01-0.32-0.5-0.31-0.42-0.36-0.46-0.340.02-0.39-0.33-0.45-0.12-0.16-0.42-0.44-0.44-0.14-0.44-0.33
0.990.990.73-0.140.82-0.810.880.98-0.060.97-0.360.950.990.660.930.980.980.75-0.050.970.970.940.620.97-0.23
0.940.950.53-0.20.66-0.660.870.93-0.070.97-0.460.950.920.450.810.910.940.590.120.970.970.970.740.97-0.23
1.00.980.73-0.070.85-0.780.840.98-0.140.96-0.340.990.920.650.930.970.990.75-0.10.960.960.930.590.96-0.31
0.610.640.96-0.090.86-0.790.440.590.10.490.020.660.450.650.770.750.60.9-0.180.50.480.420.080.48-0.04
0.910.930.830.010.89-0.820.750.93-0.10.83-0.390.930.810.930.770.950.920.870.010.840.850.790.330.84-0.23
0.960.980.81-0.140.87-0.820.840.95-0.020.93-0.330.980.910.970.750.950.960.82-0.010.930.930.890.560.93-0.19
0.990.980.7-0.110.81-0.730.851.0-0.080.97-0.450.980.940.990.60.920.960.71-0.10.980.980.950.610.97-0.25
0.720.730.870.240.84-0.790.480.710.00.62-0.120.750.590.750.90.870.820.710.090.630.620.570.150.62-0.1
-0.09-0.04-0.240.35-0.20.01-0.15-0.07-0.04-0.07-0.16-0.050.12-0.1-0.180.01-0.01-0.10.09-0.07-0.05-0.04-0.09-0.050.06
0.980.970.6-0.160.72-0.660.90.96-0.051.0-0.420.970.970.960.50.840.930.980.63-0.071.00.990.761.0-0.22
0.980.970.58-0.130.71-0.650.890.96-0.081.0-0.440.970.970.960.480.850.930.980.62-0.051.00.990.751.0-0.24
0.960.940.52-0.140.65-0.60.880.94-0.041.0-0.440.940.970.930.420.790.890.950.57-0.040.990.990.81.0-0.21
0.640.650.16-0.340.27-0.270.750.560.060.77-0.140.620.740.590.080.330.560.610.15-0.090.760.750.80.76-0.11
0.980.970.58-0.140.71-0.650.890.96-0.071.0-0.440.970.970.960.480.840.930.970.62-0.051.01.01.00.76-0.23
-0.29-0.23-0.1-0.31-0.430.15-0.17-0.230.97-0.22-0.33-0.23-0.23-0.31-0.04-0.23-0.19-0.25-0.10.06-0.22-0.24-0.21-0.11-0.23
Click cells to compare fundamentals

TransMedics Account Relationship Matchups

TransMedics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets105.3M152.0M134.9M277.1M706.0M741.3M
Total Current Liabilities16.1M11.9M23.2M23.7M54.9M57.7M
Total Stockholder Equity54.6M103.9M67.9M187.4M137.2M144.1M
Other Liab1.1M759K389K1.6M1.4M901.6K
Net Tangible Assets54.6M103.9M67.9M187.4M215.5M226.3M
Retained Earnings(369.5M)(398.2M)(442.4M)(478.7M)(503.7M)(528.9M)
Accounts Payable7.2M1.2M6.7M3.3M12.7M13.4M
Cash20.1M24.6M25.6M201.2M394.8M414.6M
Long Term Debt34.1M34.7M35.2M58.7M506.2M531.5M
Inventory11.2M11.9M14.9M20.6M44.2M46.4M
Total Liab50.7M48.1M67.0M89.8M568.8M597.3M
Total Current Assets100.0M146.8M118.7M252.3M510.7M536.2M
Common Stock424.1M502.2M510.5M666.3M641.1M375.9M
Property Plant Equipment4.8M4.8M15.7M24.4M28.0M29.4M
Other Current Liab8.7M10.4M16.3M18.6M38.2M40.1M
Net Receivables6.6M6.9M5.9M27.6M63.6M66.8M
Common Stock Shares Outstanding14.2M24.7M27.6M29.6M32.5M24.3M
Other Stockholder Equity(105.3M)(95K)68.0M(225K)(202.5K)(192.4K)
Short Long Term Debt Total34.1M34.7M43.8M67.6M515.9M541.7M
Property Plant And Equipment Net4.8M4.8M15.7M24.4M180.5M189.5M
Current Deferred Revenue166K263K250K241K2.0M2.1M
Net Debt14.1M10.1M(17.0M)(133.6M)121.1M127.2M
Non Current Assets Total5.3M5.3M16.2M24.9M195.4M205.2M
Cash And Short Term Investments80.7M125.6M92.5M201.2M394.8M414.6M
Common Stock Total Equity331.2M424.1M502.2M510.5M587.1M389.0M
Long Term Debt Total33.7M34.1M34.7M35.2M40.5M31.8M
Liabilities And Stockholders Equity105.3M152.0M134.9M277.1M706.0M741.3M
Non Current Liabilities Total34.5M36.3M43.8M66.1M513.9M539.6M
Other Current Assets1.5M2.3M5.5M2.9M8.0M8.4M
Net Invested Capital88.8M138.5M103.1M246.1M643.4M675.6M
Property Plant And Equipment Gross4.8M4.8M15.7M24.4M201.8M211.9M
Accumulated Other Comprehensive Income(2K)(95K)(188K)(225K)(199K)(209.0K)
Net Working Capital83.9M134.9M95.5M228.6M455.7M478.5M
Capital Stock424.1M502.2M510.5M666.3M641.1M563.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.